PathogenDx has developed a microarray based test specifically designed for the cannabis, botanical, food and agricultural testing markets. Founded by Eric Lachance, Michael Hogan, and Milan Patel in 2015, PathogenDx is backed by investors that include Altitude Investment Management, Cresco Capital Partners, Flatiron Partners, HALLEY Venture Partners, and Salveo Capital and is headquartered in Scottsdale.